DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Moclobemide is an investigational drug.
There have been 6 clinical trials for Moclobemide. The most recent clinical trial was a Phase 3 trial, which was initiated on November 1st 2008.
The most common disease conditions in clinical trials are Sialorrhea, Tobacco Use Disorder, and Behavior, Addictive. The leading clinical trial sponsors are Beersheva Mental Health Center, Tirat Carmel Mental Health Center, and National Institute on Drug Abuse (NIDA).
Recent Clinical Trials for Moclobemide
|Establishment of Cessation Therapy by Clinical Trials for Subjects With Betel-quid Dependence and Oral Pre-cancer||China Medical University Hospital||Phase 2|
|Pharmacovigilance in Gerontopsychiatric Patients||Hannover Medical School||Phase 3|
|Evaluation of Moclobemide, a Reversible MAO-A Inhibitor, as an Adjunct to Nicotine Replacement Therapy in Female Smokers||National Institute on Drug Abuse (NIDA)||Phase 2|